Edition:
United Kingdom

Caladrius Biosciences Inc (CLBS.OQ)

CLBS.OQ on NASDAQ Stock Exchange Capital Market

4.72USD
5:58pm BST
Change (% chg)

$0.13 (+2.83%)
Prev Close
$4.59
Open
$4.57
Day's High
$4.72
Day's Low
$4.57
Volume
1,266
Avg. Vol
49,651
52-wk High
$11.65
52-wk Low
$2.65

Chart for

About

Caladrius Biosciences, Inc. is a cell therapy development company with product candidates in development based on multiple technology platforms and targeting autoimmune and cardiology indications. The Company's lead product candidate, CLBS03, is a T regulatory cell (Treg) clinical Phase II therapy targeting adolescents with... (more)

Overall

Beta: 1.58
Market Cap(Mil.): $32.35
Shares Outstanding(Mil.): 8.91
Dividend: --
Yield (%): --

Financials

  CLBS.OQ Industry Sector
P/E (TTM): -- 86.20 32.69
EPS (TTM): -2.78 -- --
ROI: -47.46 0.73 14.32
ROE: -70.71 1.82 16.04

Earnings vs. Estimates